Zeo ScientifiX (ZEOX) Operating Margin (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Operating Margin of 19.84% for Q2 2026, up 10149.0% year-over-year from N/an in Q2 2025, and up 67.33% quarter-over-quarter from 60.72% in Q1 2026.
Zeo ScientifiX (ZEOX) Operating Margin (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Operating Margin history runs 15 years deep, the most recent figure standing at 19.84% for Q2 2026.
- In Q2 2026, Operating Margin rose 10149.0% year-over-year to 19.84%; the TTM figure through Apr 2026 stood at 59.1% (up 5547.0% YoY), while the FY2025 annual figure was 103.6%, up 1153.0% from the prior year.
- Operating Margin for Q2 2026 stood at 19.84%, up from 60.72% in the prior quarter.
- The five-year high for Operating Margin was 19.84% in Q2 2026, with the low at 226.39% in Q2 2023.
- The 5-year median for Operating Margin is 114.75% (2024), against an average of 120.44%.
- Peak annual rise in Operating Margin reached 49405 bps in 2022, while the deepest fall reached 16320 bps in 2022.
- Zeo ScientifiX's Operating Margin stood at 220.36% in 2022, then soared by 61 bps to 86.64% in 2023, then sank by 32 bps to 114.55% in 2024, then jumped by 65 bps to 40.39% in 2025, then surged by 51 bps to 19.84% in 2026.
- Business Quant data shows ZEOX's Operating Margin at 19.84% in Q2 2026, 60.72% in Q1 2026, and 40.39% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn | -19.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -19.84% |
| Jan 31, 2026 | -60.72% |
| Oct 31, 2025 | -40.39% |
| Jul 31, 2025 | -158.58% |
| Apr 30, 2025 | -121.32% |
| Jan 31, 2025 | -114.95% |
| Oct 31, 2024 | -114.55% |
| Jul 31, 2024 | -107.06% |
| Apr 30, 2024 | -138.28% |
| Jan 31, 2024 | -100.69% |
| Oct 31, 2023 | -86.64% |
| Jul 31, 2023 | -118.43% |
| Apr 30, 2023 | -226.39% |
| Jan 31, 2023 | -203.36% |
| Oct 31, 2022 | -220.36% |
| Jul 31, 2022 | -161.24% |
| Apr 30, 2022 | -72.52% |
| Jan 31, 2022 | -102.64% |
| Oct 31, 2021 | -57.16% |
| Jul 31, 2021 | -101.83% |